-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

Dow Jones·07/14/2026 10:02:00

Please log in to view news